SELLAS Life Sciences (SLS) EBIT Margin (QoQ) (2012 - 2021)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | SELLAS Life Sciences | 1.61 Bn | 1.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | -19,498.00 |
| Mar 31, 2021 | 17,951.00 |
| Jun 30, 2015 | 5,550.00 |
| Mar 31, 2015 | -2,069.00 |
| Dec 31, 2014 | 34,890.00 |
| Sep 30, 2014 | 2,481.00 |
| Jun 30, 2014 | -13,181.00 |
| Mar 31, 2014 | -32,622.00 |
| Dec 31, 2013 | 20,643.00 |
| Sep 30, 2013 | -8,289.00 |
| Jun 30, 2013 | -3,837.00 |
| Mar 31, 2013 | -78,099.00 |
| Dec 31, 2012 | 94,923.00 |